---
title: "Frazier Life Sciences Holdings II LLC Discloses Investment at Frazier Life Sciences Acquisition Corp. II with 20.5% Stake"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/302615118.md"
description: "Frazier Life Sciences Holdings II LLC disclosed a 20.5% stake in Frazier Life Sciences Acquisition Corp. II (FLSC). The position includes shares acquired before and alongside the SPAC's October 15, 2026 IPO, comprising 300,000 Class A shares from private placement and convertible Class B founder shares. The sponsor holds the shares for investment purposes and may engage in further transactions or strategic moves, though no specific plans are currently in place."
datetime: "2026-10-21T21:46:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/302615118.md)
  - [en](https://longbridge.com/en/news/302615118.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/302615118.md)
generator: "portal-rs"
---

# Frazier Life Sciences Holdings II LLC Discloses Investment at Frazier Life Sciences Acquisition Corp. II with 20.5% Stake

Frazier Life Sciences Holdings II LLC disclosed a 20.5% stake in Frazier Life Sciences Acquisition Corp. II. The position reflects shares acquired before and alongside the SPAC’s October 15, 2026 IPO, including 300,000 Class A shares bought in a private placement. The sponsor also holds Class B founder shares that can convert into Class A at the time of a business combination.

**Investor Intent**

Frazier Life Sciences Holdings II LLC says it holds the shares for investment and may buy or sell more. The sponsor may talk with other shareholders about potential transactions and “the acquisition or disposition of Ordinary Shares, including through derivative transactions.”

The sponsor also keeps its options open on strategic moves, including changes to leadership or a deal. It may consider “an extraordinary corporate transaction, such as a merger, reorganization or liquidation,” though it reports no specific plans today.

**Investor's Background**

Frazier Life Sciences Holdings II LLC is a Cayman Islands entity affiliated with Frazier Life Sciences, a venture platform focused on healthcare and biotech. The firm invests across private and public life sciences companies with a hands-on approach to company building. Frazier-backed teams have launched and financed numerous therapeutics companies across drug development stages.

Original SEC Filing: Frazier Life Sciences Acquisition Corp. II \[ FLSC \] - SCHEDULE 13D - Oct. 21, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [FLSC.US](https://longbridge.com/en/quote/FLSC.US.md)

## Related News & Research

- [Frazier Life Sciences Acquisition II Raises $78 Million in IPO and Private Placement](https://longbridge.com/en/news/302781770.md)
- [Top Executive Makes Bold Move with Major Stake in Life Sciences Firm](https://longbridge.com/en/news/302045349.md)
- [Eli Lilly (LLY) Enters Cancer Licensing Deal Worth $5.9 Billion](https://longbridge.com/en/news/305855448.md)
- [AI’s 48-Hour Stress Test Starts Now](https://longbridge.com/en/news/305878236.md)
- [Recursion Reaches FDA Alignment on Phase 3 Trial Design for REC-4881 in FAP](https://longbridge.com/en/news/305952115.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**